Volume 5, Issue 4 (17 2006)                   ijdld 2006, 5(4): 319-324 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Javad Zavar Reza, Mahmoud Dousti, Sadigheh Soleimani, Farzad Asadi Jamnani, Bardia Farzamfar, Shahrnaz Aria Barzin et al . EFFECTS OF PERSIAN WALNUT (LAVASANATREGION) OIL EXTRACT ON LIPID PROFILE IN ANIMAL MODEL (HYPERCHOLESTEROLEMIC MALE RATS). ijdld 2006; 5 (4) :319-324
URL: http://ijdld.tums.ac.ir/article-1-348-en.html
Abstract:   (9659 Views)
Background: Experimental studies have shown that walnut (Juglans regia) intake decreases the risk of coronary heart disease (CHD). Walnut decreases the levels of atherogenic lipids such as TG, LDL-C and VLDL-C. Mainly the effect is induced via 3- Poly Unsaturated Fatty Acids (3-PUFA). Walnuts are a rich source of these fatty acids, especially -Linolenic acid (C18:3 9, 12, 15).
Methods: We assigned 20 hypercholesterolemic male Rats (200-250g) to four groups, and fed with four diet concentration of oil extract Persian walnuts(J. regia)(Lavasanate) (w/w ) as complementary diet: control group (0% oil extract) and cases 5%(1g oil extract/1g weight/1 day) ,7.5%(1.5g oil extract/1g weight/1 day),10%(1g oil extract/1g weight/1 day) for eight weeks.
Results: Results revealed there is a positive effect on the decreasing of TG(14%) ,TC(7.8%) , LDL-C(11%),VLDL-C(12%) serum concentrations, with increasing consumption of oil extract Persian walnuts (5% ,7.5% and 10%).
Conclusion: In view of the positive effect of oil extract Persian walnuts (J. regia) consumption on decrease serum concentration of TG, TC, LDL-C and VLDL-C known as atherogenic lipids and lipoproteins, it may be suggested as a CHD protective dietary supplement.
Full-Text [PDF 177 kb]   (2142 Downloads)    
Type of Study: Research | Subject: General
Received: 2006/02/18 | Accepted: 2006/06/23 | Published: 2013/10/3

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by: Yektaweb